U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07227870) titled 'L19IL2/TNF in Patients With Basal Cell Carcinoma' on Nov. 07.
Brief Summary: Open-label, single-arm, multicentre study in patients with locally advanced BCC amenable to intratumoral injection, who have progressed on or are intolerant to systemic therapy as determined by a local multidisciplinary tumor board. The primary objective of the study is to evaluate the activity of intratumoral L19IL2/L19TNF, while the secondary objective is to assess the safety and efficacy. The patients will receive multiple intratumoral administrations of combined L19IL2 and L19TNF to all injectable cutaneous and subcutaneous lesions once weekly for up to...